Galecto, Inc. (GLTO)
24.00
-1.26
(-4.99%)
USD |
NASDAQ |
Feb 09, 16:00
23.46
-0.54
(-2.25%)
After-Hours: 20:00
Galecto EPS Diluted (Quarterly) : -2.361 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.5884 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| AnaptysBio, Inc. | 0.5208 |
| Ovid Therapeutics, Inc. | -0.171 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.133M |
| Total Expenses (Quarterly) | 3.133M |
| Enterprise Value | 32.03M |
| Earnings Yield | -50.42% |
| Normalized Earnings Yield | -40.48 |